Evidence map›Paper›PMID 30034366›Full record

ReviewFrontiers in endocrinology2018

Transcriptional Regulation of Glucose Metabolism: The Emerging Role of the HMGA1 Chromatin Factor.

Eusebio Chiefari, Daniela P Foti, Riccardo Sgarra, Silvia Pegoraro, Biagio Arcidiacono, Francesco S Brunetti, Manfredi Greco, Guidalberto Manfioletti, Antonio Brunetti

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in endocrinology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Structure and Functions of HMGB2 Protein.International journal of molecular sciences · 2023
    Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Eusebio ChiefariDepartment of Health Sciences, University "Magna Græcia" of Catanzaro, Catanzaro, Italy.
Daniela P FotiDepartment of Health Sciences, University "Magna Græcia" of Catanzaro, Catanzaro, Italy.
Riccardo SgarraDepartment of Life Sciences, University of Trieste, Trieste, Italy.
Silvia PegoraroDepartment of Life Sciences, University of Trieste, Trieste, Italy.
Biagio ArcidiaconoDepartment of Health Sciences, University "Magna Græcia" of Catanzaro, Catanzaro, Italy.
Francesco S BrunettiDepartment of Medical and Surgical Sciences, University "Magna Græcia" of Catanzaro, Catanzaro, Italy.
Manfredi GrecoDepartment of Clinical and Experimental Medicine, University "Magna Græcia" of Catanzaro, Catanzaro, Italy.
Guidalberto ManfiolettiDepartment of Life Sciences, University of Trieste, Trieste, Italy.
Antonio BrunettiDepartment of Health Sciences, University "Magna Græcia" of Catanzaro, Catanzaro, Italy.
Magna Graecia University · ITUniversity of Trieste · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

HMGA1 (high mobility group A1) is a nonhistone architectural chromosomal protein that functions mainly as a dynamic regulator of chromatin structure and gene transcription. As such, HMGA1 is involved in a variety of fundamental cellular processes, including gene expression, epigenetic regulation, cell differentiation and proliferation, as well as DNA repair. In the last years, many reports have demonstrated a role of HMGA1 in the transcriptional regulation of several genes implicated in glucose homeostasis. Initially, it was proved that HMGA1 is essential for normal expression of the insulin receptor (INSR), a critical link in insulin action and glucose homeostasis. Later, it was demonstrated that HMGA1 is also a downstream nuclear target of the INSR signaling pathway, representing a novel mediator of insulin action and function at this level. Moreover, other observations have indicated the role of HMGA1 as a positive modulator of the Forkhead box protein O1 (FoxO1), a master regulatory factor for gluconeogenesis and glycogenolysis, as well as a positive regulator of the expression of insulin and of a series of circulating proteins that are involved in glucose counterregulation, such as the insulin growth factor binding protein 1 (IGFBP1), and the retinol binding protein 4 (RBP4). Thus, several lines of evidence underscore the importance of HMGA1 in the regulation of glucose production and disposal. Consistently, lack of HMGA1 causes insulin resistance and diabetes in humans and mice, while variations in the

Indexed as

glucose homeostasisglucose metabolismHMGA1insulin resistancetype 2 diabetes

Identifiers

PMID30034366
PMCPMC6043803
OpenAlexW2808147777

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.